Page last updated: 2024-08-23

1-deoxynojirimycin and Bone Diseases, Metabolic

1-deoxynojirimycin has been researched along with Bone Diseases, Metabolic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hachulla, E; Javier, RM1
Elstein, D; HrebĂ­cek, M; Pastores, GM; Zimran, A1

Reviews

2 review(s) available for 1-deoxynojirimycin and Bone Diseases, Metabolic

ArticleYear
[Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
    Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:12 Pt 3

    Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; Aged, 80 and over; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Child; Child, Preschool; Clinical Trials as Topic; Diphosphonates; Enzyme Inhibitors; Fractures, Bone; Gaucher Disease; Glucosylceramidase; Glycoside Hydrolase Inhibitors; Humans; Joint Diseases; Kyphosis; Magnetic Resonance Imaging; Middle Aged; Osteoarthritis; Osteonecrosis; Osteoporosis; Radionuclide Imaging; Spinal Fractures; Tomography, X-Ray Computed

2007
Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Clinical therapeutics, 2007, Volume: 29, Issue:8

    Topics: 1-Deoxynojirimycin; Adult; Bone Density; Bone Diseases, Metabolic; Enzyme Inhibitors; Female; Gaucher Disease; Glucosyltransferases; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pain; Pain Measurement; Time Factors; Treatment Outcome

2007